Who are polyethylene glycol, senna's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Sodium Picosulfate/Magnesium Citrate Laxative.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyethylene-glycol-senna.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

polyethylene glycol, senna — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

polyethylene glycol, senna (polyethylene glycol, senna) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic and stimulant laxative combination. Area: Gastroenterology.

marketed Osmotic and stimulant laxative combination Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

polyethylene glycol, senna (polyethylene glycol, senna) — Children's Hospital of Philadelphia. Polyethylene glycol and senna work together as an osmotic laxative and stimulant laxative to increase stool water content and promote bowel motility for constipation relief.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
polyethylene glycol, senna TARGET	polyethylene glycol, senna	Children's Hospital of Philadelphia	marketed	Osmotic and stimulant laxative combination
Sodium Picosulfate/Magnesium Citrate Laxative	Sodium Picosulfate/Magnesium Citrate Laxative	American University of Beirut Medical Center	marketed	Osmotic and stimulant laxative combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic and stimulant laxative combination class)

American University of Beirut Medical Center · 1 drug in this class
Children's Hospital of Philadelphia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). polyethylene glycol, senna — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-senna. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab